tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY
Advertisement

Incyte (INCY) Similar Stocks

Compare
1,760 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$84.84
$16.40B
19.10
29.27%
10 Buy
8 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$57.45
$11.03B
17.02
-35.15%
19 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$38.34
$10.20B
18.18
49.67%
9 Buy
8 Hold
0 Sell
Moderate Buy
United Therapeutics
$305.34
$13.98B
12.07
-12.57%
8 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$196.66
$11.91B
39.33%
16 Buy
1 Hold
0 Sell
Strong Buy
Genmab
$24.54
$15.12B
12.15
-11.15%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
84.84
19.20
29.25%
BMRN
BioMarin Pharmaceutical
58.66
-31.66
-35.05%
EXEL
Exelixis
38.51
12.69
49.15%
UTHR
United Therapeutics
305.34
-54.50
-15.15%
ASND
Ascendis Pharma
193.01
54.10
38.95%
GMAB
Genmab
24.78
-2.92
-10.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis